Skip to content

Difficulties and Obstacles to the Integration in Community of Children With Type 1 Diabetes Before Primary School.

Evaluation of Difficulties and Obstacles to the Integration in Community of Children With Type 1 Diabetes Before Primary School, Followed by the Diabetology Department of Lyon Pediatric Hospital.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03980353
Acronym
DIABECO
Enrollment
146
Registered
2019-06-10
Start date
2019-08-01
Completion date
2019-11-01
Last updated
2020-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Brief summary

The incidence of type 1 diabetes is increasing worldwide and in France, including among young children. Type 1 diabetes has consequences for integration in community, especially on the management of hypoglycemia and hyperglycemia, mealtimes, participation in sporting activities and school trips. This works' purpose is to describe obstacles and difficulties to the integration in community before primary school (day care center, childminder, and nursery school) of a complete sample of children with type 1 diabetes followed in the Diabetology Department of Lyon Pediatric Hospital, at the start of the school year 2018-2019. The investigating team will carry out a descriptive study, using different questionnaires addressed to the professionals (nursery school directors, day care nursery directors, childminders, school doctors, pediatricians and doctors of child and maternal protection centers) and to the parents of children with type 1 diabetes. These different questionnaires will help to take into account different points of view, in order to identify all the obstacles to integration of children with type 1 diabetes in community. Through this work, secondary information actions through training and/or information leaflets will be carried out in order to facilitate the reception of these children in the community.

Interventions

OTHERQuestionnaires

The questionnaires have two parts: a general part and a second part focused on the integration in community of the type 1 diabetes children with specific questions about blood glucose, mealtimes, sporting activities and school trips.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Months to 8 Years
Healthy volunteers
No

Inclusion criteria

Children: * Type 1 Diabetes * Followed in the diabetology department of Lyon pediatric hospital * Who are too young to go to primary school in 2018-2019 * Residing in the Rhône-Alpes region of France * No parental opposition to the completion of the questionnaire (reflection period of 15 days after receipt the leaflet information) For school directors, school doctors, pediatricians, child and maternal protection center doctors * Questionnaire responses will be considered as evidence of no opposition. Directors of nurseries and childminders who will agree to answer the telephone questionnaire after parents allow the study team to contact them

Exclusion criteria

Children: * Child requiring another facilities for school (food allergies, celiac disease…) * Language barrier not permitting a response to the questionnaires For childminders and nursery directors * refusal of parents to contact them * refusal to participate declared during the telephone interview For school directors, doctors and school doctors * No prior involvement in the reception in community of a type 1 diabetes child

Design outcomes

Primary

MeasureTime frameDescription
Identification of community integration obstacles for children with type 1 diabetes15 minutesParticipants will respond to a multi-question interview by telephone or a paper questionnaire. The questions will focus on the child's lifestyle (such as meal times, activities, blood glucose levels...) in order to identify integration obstacles

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026